Course Directors
                                     David Deitch, PhD, is the Founder of the Center for Criminality and Addiction Research, Training            

                                     and Application (CCARTA) at the currently Emeritus Professor of Clinical Psychiatry at the    

                                     University of California, San Diego. Dr. Deitch has over 45 years of experience in the development of drug                                                                        abuse treatment systems for adolescents and adults, nationally and internationally. In the non-profit public health sector, he                                      was Co-Founder of Daytop Village, Inc., and also served as Senior Vice President and Chief Clinical Officer for Phoenix House’s                                      Foundation. In the academic sector, he has had appointments at Temple University, the University of Chicago, University of                                          California at San Francisco, as well as serving as Chief of Substance Abuse Services for the University of California, San                                                  Francisco. In the government sector, he has served as Coordinator of Curriculum and Faculty for the United Nations East Central European Drug Abuse Treatment Training Project; has consulted to a variety of Department of Corrections and Ministries of Justice and Health, in Latin America, SE Asia and Europe. Dr. Deitch served during the Johnson Administration as consultant to the Presidential Commission for  the Study of Crime and Juvenile Delinquency, and the National Commission on Marijuana and Drug Abuse. During the Carter Administration, he chaired the White House Task Force on Prevention. He chaired the Curriculum Development Committee of the National Addiction Technology Transfer Centers, Technical Assistance Publication Series 21 — The Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice, used today as a guideline for corrections and community based substance abuse treatment organizations. He has further served as Regional Director of the Executive Committee of the Association for Medical Education and Research in Substance Abuse — Mentor Project (2000). He has numerous publications (and videos) in the field.


                                  Igor Koutsenok, MD, MS is а Professor of Practice in Psychiatry at the University of California San Diego, Director of the                                               Center for Criminality and Addiction Research, Training and Application, Director of the SAMHSA Addiction Technology                                                 Transfer Center-Ukraine. He graduated as a medical doctor in 1983 at the National Medical University in Kiev, (Ukraine). In                                            1986, he completed his psychiatry residency training and received degree as psychiatrist from the Medical University in Sofia                                      (Bulgaria). In 1993 -1996 he worked at the University of London, Department of Addictive Behavior and Psychological Medicine                                    at St. Georges Hospital Medical School and completed Masters Degree in Addictive Behavior. In 1996, he was recruited by the University of California San Diego, School of Medicine, Department of Psychiatry and since then he serves as faculty member  of the Department. In 2013-2016 he served as Chief of Prevention, Treatment, and Rehabilitation Branch at the United Nations Office on Drugs and Crime, United Nations Office in Vienna. Over the last 20 years Dr. Koutsenok led the design and implementation of multiple training and technical assistance programs for addiction treatment, mental health practitioners, primary health care and social work practitioners, criminal justice professionals in the United States and around the world. Dr. Koutsenok served as a trainer for the National Drug Court Institute in the USA. Dr. Koutsenok is also a member of the International Motivational Interviewing Network of Trainers (MINT). For many years, Dr. Koutsenok teaches general and addiction psychiatry to medical students, psychiatry residents, psychology trainees, social workers, criminal justice professionals, and policy makers around the world. He is a recipient of numerous national and international awards. He has authored and co-authored over 30 scientific publications and 4 book chapters. Dr. Koutsenok has been invited as a presenter and trainer to hundreds of conferences and workshops in the USA and more than 40 countries around the world. He is a proud father of three.


2018 UCSD SCI Distinguished Faculty


                       Robert M. Anthenelli, MD is Professor and Interim Chair of the Department of Psychiatry at the University of California, San Diego,                           School of Medicine where he directs the Pacific Treatment and Research Center. He previously served as the department's Executive                         Vice Chair which followed a term as Associate Chief of Staff for Mental Health at the VA San Diego Healthcare System and Vice Chair                           for Veterans Affairs. Prior to returning to UCSD in 2011, he was a Professor of Psychiatry, Psychology and Neuroscience at the                                     University of Cincinnati, College of Medicine where he founded and directed the Center for Treatment, Research & Education in Addictive Disorders and the Addiction Sciences Division.


Dr. Anthenelli earned his baccalaureate degree from The Johns Hopkins University in Baltimore, Maryland, USA and his MD degree from The Johns Hopkins University School of Medicine. After graduating medical school, he completed his internship in internal medicine at Mercy Hospital in Baltimore. Dr. Anthenelli did residency training in psychiatry at the University of California, San Diego, School of Medicine. Additional post-doctoral training included a 2-year fellowship in addiction psychiatry research that was funded by the Department of Veterans Affairs.


The overarching theme of Dr. Anthenelli’s research is to develop improved treatments for tobacco and alcohol dependence by better understanding the neurobiology of these disorders. His lab group is also interested in the relationship between stress and relapse to addiction, and sex differences in stress and treatment responsivity. Funding for his research is provided by the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, the Department of Veterans Affairs, and various industry sponsors. 
 

                            Kara S. Bagot, MD is a Child and Adolescent Psychiatrist and Assistant Professor in the University of California, San Diego                                            Department of Psychiatry. She received her psychiatric and clinical research training at Yale University Child Study Center. Dr.                                      Bagot is a clinician and researcher with expertise in treatment interventions for adolescent Substance Use Disorders, and has                                      authored and presented several manuscripts in this field. Her research focuses on understanding psychosocial, biological and                                    psychiatric factors that contribute to the developmental trajectory of substance use in adolescents, and development of efficacious treatment interventions that can be implemented in naturalistic settings.


                                 Christopher Blazes, M.D., is a board-certified addiction psychiatrist at U-M Addiction Treatment Services, as well as an                                                emergency medicine physician at U-M Hospital. Dr. Blazes has been a board certified emergency medicine physician for over                                      17 years, and his work serves as a bridge between emergency medicine and psychiatry. Dr. Blazes specializes in providing                                           pharmacologic treatment for addiction and co-occurring disorders, as well as in other non-traditional methods to addiction                                         treatment, including mindfulness practices and techniques. His treatments are highly individualized, and based on the unique needs of each patient.

Dr. Blazes received his M.D. from the University of Rochester School of Medicine and Dentistry, and his emergency medicine training at Brown University School of Medicine. Dr. Blazes has received many honors and awards. His most recent awards include the 2017 Laughlin Award for Outstanding Psychiatry Resident and the 2017 Menin Humanistic Sensitivity Award.

His research interests include developing a better understanding of the morbidities and mortality associated with benzodiazepine use, enhanced management for the process of de-prescribing benzodiazepines, as well as management of the postacute withdrawal syndrome associated with chronic benzodiazepine use. He is also involved in regional, state and national efforts to initiate addiction treatments for at risk patients from the emergency department.     


                                Anna Blyum, MS, UCA ATTC Project Coordinator - UCSDis originally from Kazakhstan. She is an alumna of E. Muskie Graduate                                     Fellowship and holds BAs in Foreign Languages and Physical Training and MS in Urban Policy Analysis and Management from                                      The New School, NYC. Currently she serves as a Project Coordinator and Motivational Interviewing Trainer at the University of  

                                California San Diego for the UCA International HIV ATTC. She is also working on her PhD degree at SDSU/UCSD Joint Doctoral                                      Program in Interdisciplinary Research on Substance Use. Her research interest lies in the interface between substance use                                          and delinquency in youth and adolescents, or, more specifically, on the evaluation of prevention and treatment policies and interventions related to this population. Prior to starting the JDP, in 2014-2017 she served as a Senior Program Officer for Central Asia and Afghanistan at the Colombo Plan International Center for Credentialing and Education of Addiction Professionals (ICCE). In this capacity she has been instrumental in the implementation of the mission to professionalize the drug demand reduction workforce work internationally, particularly in Central Asian Region, Pakistan and Afghanistan. The Training of National Trainers on the Universal Treatment Curriculum (UTC) in Kazakhstan, in particular, was initiated in the framework of joint Colombo Plan-UNODC ROCA project and under Ms. Blyum’s project coordination. As a professional in the field of substance use education, Ms. Blyum is also trained as a trainer, is credentialed internationally as International Certified Addiction Professional (ICAP I) and continues her extensive training in the field.

         


                          Thom Browne, Jr., MA Rubicon Global Enterprises: President and CEO (Aug. 2015 – present) Colombo Plan Secretariat: Chief                                      Executive Officer (Jan. 2016 – present) Provides global technical assistance on drug prevention, treatment, recovery, and criminal                                justice issues. Chairs international working groups to develop certification for addictions counselors, licensing for treatment                                       centers, and networks of treatment/prevention professionals. Serves as expert advisor to selected international organizations on    counter-narcotics issues. Develops specialized programs addressing unique international challenges such as identification of toxic               adulterants added to drugs of abuse and related public health responses. Developed the U.S. government's program and approach                         to international drug demand reduction for over 25 years as the U.S. Department of State's Division Director for Criminal Justice                               Programs.


                          Laurie Krom, MS is a Program Director in the Collaborative to Advance Health Services at the University of Missouri-Kansas City’s                              School of Nursing and Health Studies. Ms. Krom is a leader in grant development and implementation, having received multiple,                                multi-million dollar federal awards. Under funding from the US Substance Abuse and Mental Health Services Administration                                        (SAMHSA), she is the Principal Investigator of the Addiction Technology Transfer Center (TTC) Network Coordinating Office, the Co-                            Director of the Prevention TTC Network Coordinating Office, and the ATTC Co-Director of the Opioid Response Network. Ms. Krom also has funding from the President’s Emergency Plan for AIDS Relief (PEPFAR) and, through March 2019, from the Centers for Disease Control and Prevention (CDC) to build capacity in HIV prevention both in the United States and abroad. Ms. Krom’s expertise is in building and strengthening interorganizational networks to deepen the impact of public health collaborations. She is a lifelong learner in transformative education, facilitative leadership and technology transfer, and a recognized leader in the substance use disorder treatment field. She serves on numerous boards and expert panels for SAMHSA, the American Academy of Addiction Psychiatry, the US State Department’s Bureau of International Narcotics and Law Enforcement Affairs (INL), the United National Office on Drugs and Crime (UNODC) and other organizations.


                            Carla Marienfeld, MD, is an addiction psychiatrist and an Associate Clinical Professor of Psychiatry at University of                                                       California San Diego.  Clinically, she focuses on the treatment of patients with substance use disorders and co-morbid                                                   psychiatric conditions.  She previously worked at a large outpatient addiction treatment program serving over 5000                                                       patients.  Her academic interests focus on implementation research and large-data health outcomes for patients with                                                   substance use disorders, as well as training and education in Motivational Interviewing.  She attended Baylor College of                     Medicine in Houston, TX, where she completed the International Health Track, served nationally on the Board of Trustees       of the American Medical Student Association (AMSA), and earned Alpha Omega Alpha (AOA) Medical Honors Society and Honors distinction.  During psychiatry residency at Yale, she served as chief resident, a National Institute of Drug Abuse R25 Research Fellow, and as the resident representative to the Accreditation Council for Graduate Medical Education (ACGME), while also earning several awards and fellowships.  She completed a fellowship in Addiction Psychiatry at Yale.  During residency and her early faculty years, she founded and led the Yale Global Mental Health Program.  She served as the site training director for the Yale New Haven Hospital Addiction Psychiatry Fellowship and supervised and taught medical students for psychiatry, residents for global mental health, and fellows for addiction psychiatry.  She has come to UCSD to help in the development and implementation of a new Addiction Recovery and Treatment Program.  This will be a full service ambulatory program for the treatment of substance use and other co-occurring mental disorders (i.e. anxiety, depression, PTSD), offering a continuum of services including a comprehensive evaluation, individual, family and group therapy, medication management, and linkage to community resources.  She is the Director for Addiction Services and the Medical Director of the Addiction Recovery and Treatment Program at UCSD.



                             Marc A. Schuckit, MD, is Professor of Psychiatry and Director of the Alcohol and Drug Treatment Program, University of                                              California, San Diego and the VA San Diego Healthcare System.  Dr. Schuckit received his BS from the University of                                                         Wisconsin, an MD from Washington University, interned at Cedars Sinai Medical Center, and was a resident in psychiatry at                                         Washington University and UCSD. He was a special advisor to the Commanding Officer of the Naval Health Research                                                     Center, and the first Director of the Alcohol and Drug Institute, University of Washington (1975-1978). He returned to San                                             Diego as Professor and Director of the Alcohol and Drug Treatment Program, University of California, San Diego and the VA           San Diego Healthcare System. Dr. Schuckit’s major focus is alcohol and drugs. He was Chair of the DSM-IV substance                   disorders workgroup and has published papers about the optimal diagnostic criteria for substance use disorders.  Regarding the genetics of alcoholism, he has carried out adoption studies, identified a genetic characteristic that impacts on elevated alcoholism risk (the low level of response to alcohol), and is now searching for related genes. He is currently completing a 20-year follow-up (97% success rate) of sons of alcoholics where he is trying to identify environmental events that might relate to whether biological predisposition toward alcohol dependence is expressed. An additional research area is co-morbidity between substance use disorders and major psychiatric conditions.

Dr. Schuckit directs the Alcohol and Drug Treatment Program at the VA San Diego Healthcare System, supervising residents, medical students and staff. He is also a major contact person regarding alcohol and drug problems in faculty and staff at UCSD and the San Diego VA. Additional clinical interests include the treatment of depressive disorders, anxiety conditions, and geriatric psychiatric populations.



                             Joseph Skrajewski, MA, MFTI, is executive director of Medical and Professional Education at the Hazelden Betty Ford                                                   Foundation. He leads the Summer Institute for Medical Students (SIMS), Professionals in Residence (PIR) program, Addiction                                       Medicine Fellowship, and Course on Addiction and Recovery Education (CARE), while also overseeing program design,                                                   development and medical education partnerships. Joseph serves on the board of the Desert Chapter of the California                                                   Association of Marriage and Family Therapists and as an Adjunct Clinical Instructor of Family Medicine at the University of                                             Southern California's Keck School of Medicine. He has presented all over the world on numerous topics related to addiction, and is a person in long-term recovery himself. Before entering the fields of psychology and healthcare, Joseph worked on Wall Street.


                 
                                Geoff Twitchell, PhD is a Licensed Clinical Psychologist with advanced training and expertise in addiction, treatment of co-                                          occurring mental health disorders, Trauma Informed Care and evidence based treatments to reduce recidivism in juvenile and                                    adult justice involved populations. He obtained his Bachelor’s degree in Psychology from the University of Washington, his                                            doctorate in Clinical Psychology from Michigan State University and he completed a postdoctoral fellowship at UCLA’s                                                    Integrated Substance Abuse Programs.   

Dr. Twitchell took his position as Treatment Director for the San Diego County Probation Department in September 2013. In this new position for Probation, he has assumed responsibility for identifying, implementing and evaluating evidence-based treatments for justice-involved populations, including those with co-occurring mental illness.  He developed the Trauma Responsive Unit in Juvenile Hall to address the needs of youth who often present with symptoms related to early and repeated trauma, including substance use. Dr. Twitchell is lead on an ongoing County-wide effort to evaluate justice-involved treatment programming. Most recently he assisted in development and implementation of a 6-day curriculum (Justice Involved Services Training Academy-JISTA). This academy is designed to educate and train treatment providers in the use of best practices when addressing the unique characteristics and needs of individuals coming into contact with the justice system, including the large subpopulation that suffers from severe mental illness. Dr. Twitchell serves as the Clinical Liaison to Juvenile and Adult Superior Courts, community treatment providers, Behavioral Health Services, Sheriff’s Department, District Attorney’s Office, and Office of the Public Defender. Dr. Twitchell co-chairs the County Health and Justice Integration Committee. He also holds a clinical appointment at UCSD School of Medicine’s Department of Psychiatry and he facilitates intern and practicum field placements in Probation for SDSU School of Social Work undergraduate and graduate students.

Summer clinical institute in addiction studies